Targeted Therapies for Multiple Myeloma

Multiple myeloma continues to be a challenging disorder to treat despite improved therapies and the widespread use of proteasome inhibitors and immunomodulatory drugs. Although patient outcomes have improved, the disease continues to invariably relapse, and in the majority of cases, a cure remains e...

Descripción completa

Detalles Bibliográficos
Autores principales: Leow, Christopher Chang-Yew, Low, Michael Sze Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145732/
https://www.ncbi.nlm.nih.gov/pubmed/33922567
http://dx.doi.org/10.3390/jpm11050334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145732/
https://www.ncbi.nlm.nih.gov/pubmed/33922567
http://dx.doi.org/10.3390/jpm11050334

Ejemplares similares